Systematic Review on Saliva Biomarkers in Patients Diagnosed with Morbus Alzheimer and Morbus Parkinson
Extracellular plaques composed of the hydrophobic peptide amyloid-β and intraneuronal accumulation of the hyperphosphorylated protein tau (p-tau) are pathological hallmarks found in the brains of most people affected by Alzheimer’s disease (AD). In Parkinson’s disease (PD), Lewy bodies, i.e., intran...
Main Authors: | Michael Wolgin, Magdalena Zobernig, Valentyn Dvornyk, Ralf J. Braun, Andrej M. Kielbassa |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-07-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/10/7/1702 |
Similar Items
-
Association between Sleep, Alzheimer’s, and Parkinson’s Disease
by: Sumire Matsumoto, et al.
Published: (2021-11-01) -
The Role of Salivary Biomarkers in the Early Diagnosis of Alzheimer’s Disease and Parkinson’s Disease
by: Patrycja Pawlik, et al.
Published: (2021-02-01) -
Salivary levels of disease-related biomarkers in the early stages of Parkinson’s and Alzheimer’s disease: A cross-sectional study
by: Masoomeh Sabaei, et al.
Published: (2023-06-01) -
Role of Astrocytes in Parkinson’s Disease Associated with Genetic Mutations and Neurotoxicants
by: Sanghoon Kim, et al.
Published: (2023-02-01) -
The Strategies of Development of New Non-Toxic Inhibitors of Amyloid Formation
by: Oxana V. Galzitskaya, et al.
Published: (2023-02-01)